2009
Ovarian Preservation by GnRH Agonists during Chemotherapy: A Meta-Analysis
Clowse ME, Behera MA, Anders CK, Copland S, Coffman CJ, Leppert PC, Bastian LA. Ovarian Preservation by GnRH Agonists during Chemotherapy: A Meta-Analysis. Journal Of Women's Health 2009, 18: 311-319. PMID: 19281314, PMCID: PMC2858300, DOI: 10.1089/jwh.2008.0857.Peer-Reviewed Original ResearchMeSH KeywordsAdultAntineoplastic Agents, HormonalAntineoplastic Combined Chemotherapy ProtocolsConfidence IntervalsControlled Clinical Trials as TopicFemaleFertilityFertility Agents, FemaleGonadotropin-Releasing HormoneHumansNeoplasmsOdds RatioOvaryPregnancyPregnancy OutcomePrimary Ovarian InsufficiencyPrognosisYoung AdultConceptsFollicle-stimulating hormoneOvarian functionOvarian preservationGnRH agonistGnRHa therapyRelative riskGnRHa-treated womenOvarian function preservationSummary relative riskRandom-effects modelEnglish-language literaturePremenopausal womenCombination chemotherapyRandomized trialsFunction preservationAutoimmune diseasesOvarian failureHematologic malignanciesMenstrual cycleReproductive agePreservation optionsGnRHaChemotherapyMeeting abstractsSmall study
2004
The Impact of Environmental Tobacco Smoke on Women's Risk of Dying from Heart Disease: A Meta-Analysis
Kaur S, Cohen A, Dolor R, Coffman CJ, Bastian LA. The Impact of Environmental Tobacco Smoke on Women's Risk of Dying from Heart Disease: A Meta-Analysis. Journal Of Women's Health 2004, 13: 888-897. PMID: 15671704, DOI: 10.1089/jwh.2004.13.888.Peer-Reviewed Original ResearchConceptsHeart diseaseCohort studyRelative riskCardiovascular diseaseEnvironmental tobacco smoke exposureRetrievable risk estimatesSummary relative riskNon-smoking womenTobacco smoke exposureHeart disease mortalityAmerican Heart AssociationEnvironmental tobacco smokeRandom-effects modelEnglish-language literatureETS exposurePassive smokeSmoke exposureHeart AssociationDisease mortalityTobacco smokeWoman's riskCounseling womenMeta-AnalysisDiseaseRisk estimates
1999
HORMONE REPLACEMENT THERAPY AND THE RISK OF COLORECTAL CANCER
Nanda K, Bastian L, Hasselblad V, Simel D. HORMONE REPLACEMENT THERAPY AND THE RISK OF COLORECTAL CANCER. Obstetrics And Gynecology 1999, 93: 880-888. DOI: 10.1097/00006250-199905001-00041.Peer-Reviewed Original ResearchHormone replacement therapyFatal colon cancerSummary relative riskRectal cancer incidenceHRT usersColon cancerColorectal cancerRelative riskReplacement therapyCancer incidenceAssociation of HRTUse of HRTRisk estimatesPostmenopausal HRT usersRecent HRT useRetrievable risk estimatesAdjusted risk estimatesMain outcome measuresConfidence intervalsDuration of useExposure of interestRandom-effects modelEnglish-language literatureTime of assessmentEstrogen usersHormone replacement therapy and the risk of colorectal cancer: a meta-analysis.
Nanda K, Bastian L, Hasselblad V, Simel D. Hormone replacement therapy and the risk of colorectal cancer: a meta-analysis. Obstetrics And Gynecology 1999, 93: 880-8. PMID: 10912438, DOI: 10.1016/s0029-7844(98)00424-4.Peer-Reviewed Original ResearchConceptsHormone replacement therapyFatal colon cancerSummary relative riskRectal cancer incidenceHRT usersColon cancerColorectal cancerRelative riskReplacement therapyCancer incidenceAssociation of HRTUse of HRTRisk estimatesPostmenopausal HRT usersRecent HRT useRetrievable risk estimatesAdjusted risk estimatesMain outcome measuresConfidence intervalsDuration of useExposure of interestRandom-effects modelEnglish-language literatureTime of assessmentEstrogen users
1998
Hormone replacement therapy and the risk of colorectal cancer: a meta-analysis
Nanda K, Bastian L, Hasselblad V, Simel D. Hormone replacement therapy and the risk of colorectal cancer: a meta-analysis. Primary Care Update For OB/GYNS 1998, 5: 165. PMID: 10838309, DOI: 10.1016/s1068-607x(98)00064-x.Peer-Reviewed Original ResearchHormone replacement therapySummary relative riskRectal cancer incidenceHRT usersColon cancerReplacement therapyCancer incidenceRelative riskUse of HRTRisk estimatesPostmenopausal HRT usersRetrievable risk estimatesColorectal cancer incidenceAdjusted risk estimatesColon cancer mortalityRisk of deathMain outcome measuresConfidence intervalsDuration of useExposure of interestRandom-effects modelEnglish-language studiesTime of assessmentEstrogen usersHRT use